Moderna Stock Down 39% in Three Months: Buy the Dip or Wait? - Yahoo Finance

Moderna Stock Down 39% in Three Months: Buy the Dip or Wait?  Yahoo Finance

‘Safety signal’ in Moderna’s RSV vaccine studies halts trials of other vaccines for childhood kil...

‘Safety signal’ in Moderna’s RSV vaccine studies halts trials of other vaccines for childhood killer  Science

Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with M...

Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna  Business Wire

FDA Committee Calls For More Research After Moderna’s RSV Vaccine Safety Issues - BioSpace

FDA Committee Calls For More Research After Moderna’s RSV Vaccine Safety Issues  BioSpace

Moderna Inc. stock underperforms Friday when compared to competitors - MarketWatch

Moderna Inc. stock underperforms Friday when compared to competitors  MarketWatch

Is Moderna Stock a Buy? - The Motley Fool

Is Moderna Stock a Buy?  The Motley Fool

Washington University participates in clinical trial of Moderna omicron booster - WashU Medicine

Washington University participates in clinical trial of Moderna omicron booster  WashU Medicine

Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Di...

Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases  PR Newswire

Moderna COVID-19 Vaccine - Winn Army Community Hospital

Moderna COVID-19 Vaccine  Winn Army Community Hospital

Northwestern University Sues Moderna Over Spikevax Vaccine - IPWatchdog.com

Northwestern University Sues Moderna Over Spikevax Vaccine  IPWatchdog.com

Moderna reports surprise profit on higher-than-expected COVID vaccine sales - Reuters

Moderna reports surprise profit on higher-than-expected COVID vaccine sales  Reuters

Franklin Resources Inc. Sells 56,346 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Franklin Resources Inc. Sells 56,346 Shares of Moderna, Inc. (NASDAQ:MRNA)  MarketBeat

After Moderna's pediatric RSV vaccine trial hold, expert panel says more testing is needed - Fier...

After Moderna's pediatric RSV vaccine trial hold, expert panel says more testing is needed  FiercePharma

mRNA vaccine from CDC and Moderna protects ferrets from current avian influenza strain - Fierce B...

mRNA vaccine from CDC and Moderna protects ferrets from current avian influenza strain  Fierce Biotech

Moderna mpox mRNA vaccine shows early promise in monkey study - Clinical Trials Arena

Moderna mpox mRNA vaccine shows early promise in monkey study  Clinical Trials Arena

What's Going On With Moderna Stock On Monday? - Yahoo Finance

What's Going On With Moderna Stock On Monday?  Yahoo Finance

Empowering the next generation: Moderna’s free course on mRNA medicines - Science

Empowering the next generation: Moderna’s free course on mRNA medicines  Science

Moderna Inc. stock outperforms competitors on strong trading day - MarketWatch

Moderna Inc. stock outperforms competitors on strong trading day  MarketWatch

Facing ‘Daunting’ Launch Schedule, Moderna to Slash $4B in R&D Spend by 2028 - BioSpace

Facing ‘Daunting’ Launch Schedule, Moderna to Slash $4B in R&D Spend by 2028  BioSpace

Moderna Gets Better-Than-Expected Q3 COVID-19 Vaccine Sales, but RSV Shot Disappoints - BioSpace

Moderna Gets Better-Than-Expected Q3 COVID-19 Vaccine Sales, but RSV Shot Disappoints  BioSpace

Moderna - OpenAI

Moderna  OpenAI

Moderna Cuts Full-Year Revenue Guidance as COVID-19 Vaccine Sales Crater in Q2 - BioSpace

Moderna Cuts Full-Year Revenue Guidance as COVID-19 Vaccine Sales Crater in Q2  BioSpace

Canada approves Moderna's RSV vaccine for adults aged 60 and older - Reuters

Canada approves Moderna's RSV vaccine for adults aged 60 and older  Reuters

Moderna said to shuffle sales leadership; Vertex records first Casgevy sale - BioPharma Dive

Moderna said to shuffle sales leadership; Vertex records first Casgevy sale  BioPharma Dive

Moderna Stock Jumps Following Bullish Sales View at Healthcare Conference - Investopedia

Moderna Stock Jumps Following Bullish Sales View at Healthcare Conference  Investopedia

Moderna Inc. stock rises Monday, still underperforms market - MarketWatch

Moderna Inc. stock rises Monday, still underperforms market  MarketWatch

HHS awards Moderna $176 million to develop mRNA H5 avian flu vaccine - University of Minnesota Tw...

HHS awards Moderna $176 million to develop mRNA H5 avian flu vaccine  University of Minnesota Twin Cities

Moderna Slashes Annual R&D Budget by $1.1B, Eyes 10 Approvals Through 2027 - BioSpace

Moderna Slashes Annual R&D Budget by $1.1B, Eyes 10 Approvals Through 2027  BioSpace

Inside Moderna’s Tech-Driven Culture: Insights From CIO Brad Miller - Forbes

Inside Moderna’s Tech-Driven Culture: Insights From CIO Brad Miller  Forbes

Moderna CEO Bancel steps down as sales chief, Bloomberg News reports - Reuters

Moderna CEO Bancel steps down as sales chief, Bloomberg News reports  Reuters

Combined COVID–flu vaccines are coming: Moderna jab clears major test - Nature.com

Combined COVID–flu vaccines are coming: Moderna jab clears major test  Nature.com

Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold - CNBC

Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold  CNBC

Blackstone Life Sciences Announces Collaboration to Support Moderna’s Influenza Program - Blackstone

Blackstone Life Sciences Announces Collaboration to Support Moderna’s Influenza Program  Blackstone

Moderna touts research progress as it cuts R&D spending by $1.1 billion - STAT

Moderna touts research progress as it cuts R&D spending by $1.1 billion  STAT

Moderna Lays Foundations for Growth, but Can It Turn Strategy Into Execution? - BioSpace

Moderna Lays Foundations for Growth, but Can It Turn Strategy Into Execution?  BioSpace

GSK Sues Moderna for Alleged Patent Infringement on COVID-19, RSV Vaccines - BioSpace

GSK Sues Moderna for Alleged Patent Infringement on COVID-19, RSV Vaccines  BioSpace

Massachusetts Tax Incentives for Moderna, Vertex and More Creating 1,155 Jobs - BioSpace

Massachusetts Tax Incentives for Moderna, Vertex and More Creating 1,155 Jobs  BioSpace

Moderna forecasts lower sales next year, shares near four-year low - Reuters

Moderna forecasts lower sales next year, shares near four-year low  Reuters

GSK sues Moderna for US patent infringement over COVID, RSV vaccines - Reuters

GSK sues Moderna for US patent infringement over COVID, RSV vaccines  Reuters

Exploring the adverse events of Oxford–AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Joh...

Exploring the adverse events of Oxford–AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain–Barré Syndrome  Nature.com

StockWatch: Moderna Seeks to Reassure Investors on RFK Jr. - Genetic Engineering & Biotechnology ...

StockWatch: Moderna Seeks to Reassure Investors on RFK Jr.  Genetic Engineering & Biotechnology News

Moderna to cut costs, trim pipeline in R&D revamp - BioPharma Dive

Moderna to cut costs, trim pipeline in R&D revamp  BioPharma Dive

Moderna, trailing rivals, checks its RSV shot expectations - BioPharma Dive

Moderna, trailing rivals, checks its RSV shot expectations  BioPharma Dive

U.S. government will pay Moderna $176 million to develop an mRNA bird flu pandemic vaccine - PBS ...

U.S. government will pay Moderna $176 million to develop an mRNA bird flu pandemic vaccine  PBS NewsHour

Moderna Scores Federal Funding For mRNA Bird Flu Vaccine As Pandemic Fears Grow - Forbes

Moderna Scores Federal Funding For mRNA Bird Flu Vaccine As Pandemic Fears Grow  Forbes

Moderna expects CDC to view its RSV vaccine as equal to rival shots - Reuters

Moderna expects CDC to view its RSV vaccine as equal to rival shots  Reuters

IDWeek 2024: Moderna’s norovirus vaccine mRNA-1403 shows potential in Phase I/II trial - Clinical...

IDWeek 2024: Moderna’s norovirus vaccine mRNA-1403 shows potential in Phase I/II trial  Clinical Trials Arena

Pfizer v Moderna COVID vaccine patents battle to go to appeal in UK - Reuters

Pfizer v Moderna COVID vaccine patents battle to go to appeal in UK  Reuters

Northwestern sues Moderna for patent infringement over COVID-19 vaccines - Reuters

Northwestern sues Moderna for patent infringement over COVID-19 vaccines  Reuters

Bird flu concern prompts US to award Moderna $176 million for vaccine development - Reuters

Bird flu concern prompts US to award Moderna $176 million for vaccine development  Reuters

US government inks a deal with Moderna to make pandemic flu vaccine - CNN

US government inks a deal with Moderna to make pandemic flu vaccine  CNN

Moderna cuts 2024 sales forecast, sees low EU vaccine revenue into 2026 - Reuters

Moderna cuts 2024 sales forecast, sees low EU vaccine revenue into 2026  Reuters

Moderna says its RSV shot is 50% effective across a second season - Reuters

Moderna says its RSV shot is 50% effective across a second season  Reuters

Moderna takes axe to '24 sales guidance, sending shares lower - FiercePharma

Moderna takes axe to '24 sales guidance, sending shares lower  FiercePharma

ESMO 2024: Moderna’s mRNA solid tumour vaccine shows early promise - Clinical Trials Arena

ESMO 2024: Moderna’s mRNA solid tumour vaccine shows early promise  Clinical Trials Arena

Moderna’s First mRNA Mpox Vaccine Beats Licensed Rival Shots In Early Testing - Forbes

Moderna’s First mRNA Mpox Vaccine Beats Licensed Rival Shots In Early Testing  Forbes

Moderna blamed after kids offered $2,000 to participate in COVID-19 vaccine trial - FiercePharma

Moderna blamed after kids offered $2,000 to participate in COVID-19 vaccine trial  FiercePharma

GSK takes mRNA patent fight to Moderna, suing over vaccines for COVID and RSV - FiercePharma

GSK takes mRNA patent fight to Moderna, suing over vaccines for COVID and RSV  FiercePharma

US nears deal to fund Moderna's bird flu vaccine trial, FT reports - Reuters

US nears deal to fund Moderna's bird flu vaccine trial, FT reports  Reuters

Stockholder Alert: Robbins LLP Informs Moderna, Inc. - GlobeNewswire

Stockholder Alert: Robbins LLP Informs Moderna, Inc.  GlobeNewswire

Moderna targets $1.1B in R&D spending cuts, drops 5 programs amid profitability pressures - Fierc...

Moderna targets $1.1B in R&D spending cuts, drops 5 programs amid profitability pressures  Fierce Biotech

Moderna shares plunge on plans to cut $1.1 billion in costs, launch 10 new products by 2027 - CNBC

Moderna shares plunge on plans to cut $1.1 billion in costs, launch 10 new products by 2027  CNBC

Moderna fends off Alnylam US patent lawsuit over COVID shots, for now - Reuters

Moderna fends off Alnylam US patent lawsuit over COVID shots, for now  Reuters

Moderna Stock Falls 20% in a Month: Time to Sell or Hold? - Yahoo Finance

Moderna Stock Falls 20% in a Month: Time to Sell or Hold?  Yahoo Finance

Moderna Stock Drops on Plans To Cut $1.1B in R&D Costs - Investopedia

Moderna Stock Drops on Plans To Cut $1.1B in R&D Costs  Investopedia

The US will pay Moderna $176 million to develop an mRNA pandemic flu vaccine - The Associated Press

The US will pay Moderna $176 million to develop an mRNA pandemic flu vaccine  The Associated Press

Former Moderna executive launches genome editing company | STAT - STAT

Former Moderna executive launches genome editing company | STAT  STAT

Should Merck Buy Out Moderna on Keytruda–Cancer Vaccine Partnership? - BioSpace

Should Merck Buy Out Moderna on Keytruda–Cancer Vaccine Partnership?  BioSpace

Moderna (MRNA) Rises Higher Than Market: Key Facts - Yahoo Finance

Moderna (MRNA) Rises Higher Than Market: Key Facts  Yahoo Finance

US pays Moderna $176m to develop bird-flu vaccine - BBC.com

US pays Moderna $176m to develop bird-flu vaccine  BBC.com

Moderna reports RSV vaccine 50% effective after 18 months - University of Minnesota Twin Cities

Moderna reports RSV vaccine 50% effective after 18 months  University of Minnesota Twin Cities

Moderna co-founder Robert Langer to step down from vaccine maker's board - Reuters

Moderna co-founder Robert Langer to step down from vaccine maker's board  Reuters

OpenAI expands partnership with Moderna for customizable GPTs - Mobihealth News

OpenAI expands partnership with Moderna for customizable GPTs  Mobihealth News

Concerns over “cosy relationship” between the FDA and Moderna - BMJ Group

Concerns over “cosy relationship” between the FDA and Moderna  BMJ Group

Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up - Reuters

Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up  Reuters

Moderna turns to AI to change how its employees work - BioPharma Dive

Moderna turns to AI to change how its employees work  BioPharma Dive

Moderna’s path to mRNA therapies for rare metabolic disorders - Drug Discovery News

Moderna’s path to mRNA therapies for rare metabolic disorders  Drug Discovery News

Moderna reports promising findings for flu-COVID combo vaccine - University of Minnesota Twin Cities

Moderna reports promising findings for flu-COVID combo vaccine  University of Minnesota Twin Cities

Moderna Cancels Kenya Vaccine Project Due to Familiar Economic Hurdles - Think Global Health

Moderna Cancels Kenya Vaccine Project Due to Familiar Economic Hurdles  Think Global Health

StockWatch: Moderna’s $1.1B R&D Cut, Profitability Delay Jolt Investors - Genetic Engineering & B...

StockWatch: Moderna’s $1.1B R&D Cut, Profitability Delay Jolt Investors  Genetic Engineering & Biotechnology News

Pfizer v Moderna COVID vaccine patents battle set to continue after UK ruling - Reuters

Pfizer v Moderna COVID vaccine patents battle set to continue after UK ruling  Reuters

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label - Reuters

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label  Reuters

Moderna COVID/flu combo vaccine superior to separate shots in trial - Reuters

Moderna COVID/flu combo vaccine superior to separate shots in trial  Reuters

Moderna Inc. stock underperforms Friday when compared to competitors - MarketWatch

Moderna Inc. stock underperforms Friday when compared to competitors  MarketWatch

US FDA pushes decision on Moderna's RSV vaccine to end of this month - Reuters

US FDA pushes decision on Moderna's RSV vaccine to end of this month  Reuters

Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine - Clinical Trials A...

Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine  Clinical Trials Arena

Moderna EU COVID-19 vaccine sales slashed as Ukraine war strains budgets, US remains strong marke...

Moderna EU COVID-19 vaccine sales slashed as Ukraine war strains budgets, US remains strong market: CEO  Yahoo Finance

Moderna mRNA manufacturing facility, Canada - Turner & Townsend

Moderna mRNA manufacturing facility, Canada  Turner & Townsend

Will people sign up for Moderna’s combo COVID-19-flu shot? Convenience may increase vaccinations,...

Will people sign up for Moderna’s combo COVID-19-flu shot? Convenience may increase vaccinations, experts say  Northeastern University

Moderna Inc. stock outperforms competitors on strong trading day - MarketWatch

Moderna Inc. stock outperforms competitors on strong trading day  MarketWatch

What to know about Moderna’s combined covid-flu vaccine on the horizon - The Washington Post

What to know about Moderna’s combined covid-flu vaccine on the horizon  The Washington Post